Physician profile
Hammad Baig
NPI 1487217022
$3,712.40
in general payments reported to CMS, 2019-2025
9 companies · $217 in 2025
The $217 reported for 2025 was more than what 82% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,675 · 2024: $1,821 · 2025: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,861 · Food and Beverage: $1,851.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,861.44 |
| Food and Beverage | $1,850.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,700.52 | 2023-2024 | Vercise, Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $708.31 | 2023-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Synchromedii |
| Nevro Corp. | $72.94 | 2024 | Senza |
| Si-Bone, INC. | $69.39 | 2025 | |
| Bioventus LLC | $50.53 | 2025 | Xcell |
| Averitas Pharma INC. | $44.27 | 2023-2024 | Qutenza |
| Avanos Medical | $26.35 | 2024 | Coolief* Cooled Radiofrequency |
| Vertex Pharmaceuticals Incorporated | $24.43 | 2025 | |
| Merck Sharp & Dohme LLC | $15.66 | 2024 | Bridion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hammad Baig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.